Overview


According to FutureWise analysis the market for Swollen Knee Treatment in 2023 is US$ 1.4 billion, and is expected to reach US$ 2.01 billion by 2031 at a CAGR of 4.60%.

Knee swelling, also known as "water on your knee", is caused by excess fluid accumulating around your knee joint. This ailment is referred to as "knee swelling" in medical terminology. Broken bones, torn ligaments and cartilage tears can cause swelling in the knee. A growing market for swollen knee treatments is expected to result from the increasing number of elderly patients and the increased frequency of musculoskeletal disorders. This includes the various steps required to place the artificial device as well as the replacement of the injured knee. A number of factors are driving the market for swollen knee treatments to increase, including increasing rates of obesity, arthritis, osteoporosis and other sports-related injuries. Contrary to popular belief, it is becoming more widely accepted by younger people due to the upcoming and existing advances in technology such as minimally invasive surgery. Although it is an effective treatment for severe diseases such as rheumatoid, the swollen-knee market is facing some difficulties. This is due to the financial slowdown that is hindering the market's growth. The market's growth is also impeded by intense competition, high surgical costs, increasing awareness of non-surgical treatments such as walking aids, shoe inserts and weight loss programs. As the world's elderly population increases, the market for swelling knees will grow. This could lead to an increase in obesity, diabetes, arthritis, and other age-related diseases. Swollen knee market growth is expected to be boosted by rising awareness in developed markets like North America and Europe about new age technology such as minimally invasive therapies. Due to the global financial crisis and a complete transformation of healthcare infrastructure to combat COVID-19, clinical trials have been canceled and product delays caused by these factors. This will undoubtedly slow down the growth of the market for knee replacement. The market growth in knee replacement treatments will be slowed by the increasing awareness about the risks and side effects of surgical replacements and a shift towards non-surgical healthcare options like therapeutic and prophylactic procedures.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Swollen Knee Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Swollen Knee Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Stryker Corporation
  • Zimmer Holdings
  • Smith & Nephew Plc
  • DePuy Companies Inc
  • Wright Medical Group Inc
  • Biomet Inc
  • Exactech
  • B.Braun melsungen AG
  • Pfizer Inc
  • MerckCo.
  • Fresenius Kabi
  • AngioDynamics
  • C.R.Bard
  • Teleflex
  • Smiths Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Medications
  • Patient-controlled analgesia pumps
  • Nerve Blocks
  • Liposomal Bupivacaine
  • Surgery

By Medications

  • Opioids
  • Corticosteroids
  • Knee Replacement

By Surgery

  • Arthrocentesis
  • Arthoscopy
  • Knee Replacement

By Knee replacement Type

  • Total Knee Replacement
  • Unicompartmental Knee Replacement
  • Others

By End-User

  • Hospitals
  • Designated Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Swollen Knee Treatment Market By Type, By Medications, By Surgery, By Knee replacement Type, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Swollen Knee Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Swollen Knee Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Swollen Knee Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Swollen Knee Treatment Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medications
        2. Patient-controlled analgesia pumps
        3. Nerve Blocks
        4. Liposomal Bupivacaine
        5. Surgery

  • 8.   Swollen Knee Treatment Market, By Medications Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Opioids
        2. Corticosteroids
        3. Knee Replacement

  • 9.   Swollen Knee Treatment Market, By Surgery Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Arthrocentesis
        2. Arthoscopy
        3. Knee Replacement

  • 10.   Swollen Knee Treatment Market, By Knee replacement Types Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Total Knee Replacement
        2. Unicompartmental Knee Replacement
        3. Others

  • 11.   Swollen Knee Treatment Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Designated Clinics
        3. Ambulatory Surgical Centers
        4. Others

  • 12.   North America Swollen Knee Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Swollen Knee Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Swollen Knee Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Swollen Knee Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Stryker Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Zimmer Holdings
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Smith & Nephew Plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. DePuy Companies Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Wright Medical Group Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Biomet Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Exactech
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. B.Braun melsungen AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Pfizer Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. MerckCo.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Fresenius Kabi
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. AngioDynamics
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. C.R.Bard
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Teleflex
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Smiths Medical
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients